Latest news

5 May 2022

BSACI response to the article (Nurek M, Rayner C, Fryer A et al. Recommendations for the recognition, diagnosis and management of long COVID. Br J Gen Pract 2021; 71:e815-e825) published online by BJGP

3 May 2022

BSACI statement: NICE approval of Palforzia, a treatment for peanut allergy in children and young people

28 Apr 2022

WAO & BSACI 2022 UK Conference a huge success

29 Mar 2022

Personalised testing for safety and effectiveness of common medicines must be offered throughout the NHS

28 Feb 2022

Watch the WAO & BSACI 2022 UK Conference Webinar online now

14 Feb 2022

WAO & BSACI 2022 UK Conference 25th-27th April 2022: guidance on travelling to Scotland - restrictions eased

31 Jan 2022

BSACI and The Canadian Society of Allergy and Clinical Immunology joint statement on oral immunotherapy

26 Jan 2022

Allergy Organisations join together to launch new guidelines to safeguard pupils with severe allergies while they are at school

10 Jan 2022

Pea protein and food allergy labelling

5 Jan 2022

WAO & BSACI 2022 UK Conference 25th-27th April 2022 – Edinburgh International Conference Centre (EICC)

20 Dec 2021

COVID-19 booster crisis for people with allergies

12 Nov 2021

Leading experts provide recommendations to support the effective and safe use of adrenaline auto-injectors

WAO & BSACI 2022 UK Conference a huge success

Read more

5 May 2022

BSACI response to the article (Nurek M, Rayner C, Fryer A...

3 May 2022

BSACI statement: NICE approval of Palforzia, a treatment for peanut allergy...